3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
118
Neoplasms
14
Neoplasm Metastasis
14
Multiple Endocrine Neoplasia Type 1
5
Advanced Breast Cancer
5
Prostatic Neoplasms
3
Hereditary Sensory and Autonomic Neuropathies
3
Breast Cancer Metastatic
3
Recurrence
2
Lymphoma
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Malignancies
1
Small Cell Lung Carcinoma
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Endometrial Stromal
1
Postmenopausal Women With ER+ HER2- Primary Breast Cancer
1
Patient Acceptance of Health Care
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms by Site
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lethal Congenital Contracture Syndrome 2
1
Hyperglycemia
1
Interventions
Radiotherapy
3
Chemotherapy, Adjuvant
3
Magnetic Resonance Spectroscopy
2
Letrozole
2
Carboplatin
2
gallium 68 PSMA-11
1
fluciclovine F-18
1
atamestane
1
Zolpidem
1
Venlafaxine Hydrochloride
1
Trastuzumab
1
Toremifene
1
Thiotepa
1
Tamoxifen
1
Reverse Transcriptase Polymerase Chain Reaction
1
Radiotherapy, Conformal
1
Radiosurgery
1
Radiation
1
Proton Therapy
1
Paclitaxel
1
Melphalan
1
Mass Spectrometry
1
Indocyanine Green
1
Immunohistochemistry
1
Histocompatibility Testing
1
Gene Expression Profiling
1
Fulvestrant
1
Fluorescent Antibody Technique
1
Estrogen Receptor Modulators
1
Drugs, Generic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Lobular
×
Fulvestrant
×
Clear all
NCT03620643
2025-10-30
ROLo
Royal Marsden NHS Foundation Trust
Phase 2
Completed
33 enrolled
13 charts